Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 4 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Docosahexaenoic Acids 2Diet 2sibutramine 1Ursodeoxycholic Acid 1Topiramate 1Solutions 1Resistance Training 1Propofol 1Progestins 1Nutrition Therapy 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Injections 1Hysteroscopy 1Exenatide 1Estrogen Replacement Therapy 1Doxorubicin 1Cyproterone 1Cyclophosphamide 1Caloric Restriction 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Obesity × Resistance Training × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡